Copenhagen - Delayed Quote DKK

ChemoMetec A/S (CHEMM.CO)

Compare
409.80 -6.60 (-1.59%)
At close: October 25 at 4:59 PM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in DKK.
NameTitlePayExercisedYear Born
Mr. Martin Helbo Behrens CEO & COO 2.92M -- 1992
Mr. Hans Martin Glensbjerg Deputy Chairman & Senior Advisor -- -- 1959
Mr. Kim Nicolajsen Chief Financial Officer -- -- 1980
Mr. Christopher Runchel M.Sc., Ph.D. Chief Sales Officer -- -- --
Marta Anglada Planaguma Chief Marketing & Strategy Officer -- -- --
Ms. Lisbet Helles Head of Marketing -- -- --
Mr. S?ren Kj?rulff Head of R&D -- -- --
Mr. Bo Melholt Nielsen Chief R&D Officer and Physicist & Project Manager -- -- --

ChemoMetec A/S

Gydevang 43
Aller?d, 3450
Denmark
45 48 13 10 20 https://chemometec.com
Sector:?
Healthcare
Industry:?
Medical Devices
Full Time Employees:?
174

Description

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops as well as develops XcytoMatic 30 cell counter. ChemoMetec A/S was incorporated in 1997 and is headquartered in Aller?d, Denmark.

Corporate Governance

ChemoMetec A/S’s ISS Governance QualityScore as of October 1, 2024 is 9. The pillar scores are Audit: 7; Board: 9; Shareholder Rights: 1; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 7, 2024 at 10:59 AM UTC

ChemoMetec A/S Earnings Date

Recent Events

October 11, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers